Key facts
- This page summarizes Everett Cunningham's Form 3 filing for EXACT SCIENCES CORP (EXAS).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Nov 2021, 16:02.
Everett Cunningham - 01 Nov 2021 Form 3 Insider Report for EXACT SCIENCES CORP (EXAS)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- EXAS
- Reported as of
- 01 Nov 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Nov 2021, 16:02:56 UTC
- Next SEC filing
- 01 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Everett Cunningham filed Form 3 for EXACT SCIENCES CORP (EXAS) on 05 Nov 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXAS
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,010
- Exercise price
- Footnotes
- F1, F2
EXAS
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,005
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents a restricted stock unit award that vests in three equal annual installments beginning on October 11, 2022.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of common stock.
Footnote F3
Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024.